首页 › 间质性肺病 › 南卡罗来纳州 › Charleston
Charleston SC 间质性肺病临床试验
13项针对 间质性肺病的研究正在 Charleston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
招募中3 期
- Lowcountry Lung and Critical Care, Charleston
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- Medical University of South Carolina, Charleston
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中2 期
- MUSC, Charleston
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
招募中
- Medical University of South Carolina, Charleston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
招募中2 期
- Medical University of South Carolina, Charleston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Charleston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
招募中
- Medical University of South Carolina, Charleston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中观察性研究
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- Medical University of South Carolina (MUSC), Charleston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
招募中观察性研究
- Medical University of South Carolina, Charleston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- Medical University of South Carolina-Nexus, Charleston
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
招募中观察性研究
- Medical University of South Carolina, Charleston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
招募中2 期
- aTyr Investigative Site, Charleston
其他城市的 间质性肺病试验
- New York City, NY18 项研究
- Philadelphia, PA16 项研究
- Los Angeles, CA14 项研究
- Kansas City, KS13 项研究
- Durham, NC13 项研究
- Chicago, IL12 项研究
- Houston, TX12 项研究
- Aurora, CO11 项研究
- Ann Arbor, MI11 项研究
- Dallas, TX9 项研究
- Salt Lake City, UT9 项研究
- Boston, MA9 项研究
Charleston的其他研究
- 抑郁症19 项研究
- 卒中18 项研究
- 心力衰竭18 项研究
- 非小细胞肺癌16 项研究
- 创伤后应激障碍16 项研究
- 心血管疾病15 项研究
- 前列腺癌15 项研究
- 癌症（所有类型）14 项研究
- 头颈鳞状细胞癌14 项研究
- 帕金森病13 项研究
- 乳腺癌12 项研究
- 肺癌11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。